Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg
Clinical trial NCT00730197 · COMPLETED
Trial details
- NCT number
- NCT00730197
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2007-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.